Mississippi Law TV® is part of the Law TV® Network, a video driven legal directory that features quality educational videos from some of the state’s premier law firms.
The legal directory includes a comprehensive listing for each law firm, including how to reach the firm directly or on social media.
The complaint alleges the defendants are intentionally infringing on Subway's trademarks and operating their Sub Sub restaurant using Subway's...
Continue Reading
U.S. District Judge Allison D. Burroughs of the District of Massachusetts entered a default judgment in favor of Jumpsource, partially granting their...
Continue Reading
Chancellor Kathaleen McCormick of the Delaware Court of Chancery wrote in January that Tesla CEO Elon Musk "wields unusually expansive managerial...
Continue Reading
Cozen O'Connor is moving into Little Rock with the hire of a former Arkansas attorney general, while Faegre Drinker's hire arrives from Troutman...
Continue Reading
"This new clemency initiative is a cornerstone of our administration's efforts to make New Jersey the state of second chances," Gov. Phil Murphy said...
Continue Reading
Amazon cited a growing trend among attorneys to corner niche markets by suing specific corporations by gleaning inside knowledge through expansive...
Continue Reading
In a proposal he said “many will reflexively condemn as heresy,” Judge Kevin Newsom suggests that those who follow an “ordinary meaning” approach to law should consider how AI-powered LLMs like ChatGPT can “inform the interpretive analysis.”
“At bottom, American Alliance and its members have shown nothing more than flopping on the field when it comes to establishing an injury in fact,” Eleventh Circuit Judge Robin Rosenbaum wrote in dissent.
Businesses and governments are “grappling with how to set boundaries while staying competitive in the technology transformation race,” FTI Technology Global CEO Sophie Ross said.
“Standard 206 seemingly asks law schools to defy the Court’s clear directive,” the AGs said in their letter, adding that proposed revisions “do little to solve these problems.”
“We will continue to pursue legal action against those who provide potentially unsafe and ineffective compounded ‘semaglutide’ products and knowingly deceive patients who are seeking treatment, thereby eroding public trust in the safety of FDA-approved medicines,” said Doug Langa, executive vice president, North America operations and president of Novo Nordisk.